CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test
At DNA Labs UAE, we offer the CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test. This test is designed to identify mutations or variants in the CA2 gene that are associated with osteopetrosis, specifically the autosomal recessive type 3 (ARO3) form of the disease.
Test Details
Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth. By analyzing the CA2 gene using Next-Generation Sequencing (NGS) technology, our healthcare professionals can determine if a person carries mutations in the gene that may cause ARO3 osteopetrosis.
Components and Price
The price of the CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test is 4400.0 AED. The test can be performed using blood or extracted DNA, or even just one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test is performed using NGS technology, which allows for the simultaneous analysis of multiple genes or even the entire genome.
Test Type and Doctor
The CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test falls under the category of Osteology Dermatology Immunology Disorders. It is recommended to consult with a dermatologist for this test.
Test Department
The CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test is conducted in our Genetics department.
Pre Test Information
Before undergoing the CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the CA2 Gene Osteopetrosis Autosomal Recessive Type 3 NGS Genetic DNA Test gene CA2.
Importance of Genetic Testing
Genetic testing can help in diagnosing the condition, predicting the risk of developing the disease in family members, and providing genetic counseling for affected individuals and their families. However, it is crucial that genetic testing is performed and interpreted by healthcare professionals with expertise in genetics to ensure accurate and comprehensive information about the implications of the test results.
| Test Name | CA2 Gene Osteopetrosis autosomal recessive type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CA2 Gene Osteopetrosis, autosomal recessive type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CA2 Gene Osteopetrosis, autosomal recessive type 3 NGS Genetic DNA Test gene CA2 |
| Test Details |
The CA2 gene is associated with a condition called osteopetrosis, specifically the autosomal recessive type 3 (ARO3) form of the disease. Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of ARO3 osteopetrosis, NGS genetic testing can be used to identify mutations or variants in the CA2 gene that are associated with the disease. By analyzing the CA2 gene using NGS, healthcare professionals can determine if a person carries mutations in the gene that may cause ARO3 osteopetrosis. This information can be helpful in diagnosing the condition, predicting the risk of developing the disease in family members, and providing genetic counseling for affected individuals and their families. It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics, as they can provide accurate and comprehensive information about the implications of the test results. |
